PHYSIOMICS PLC Logo

PHYSIOMICS PLC

De-risks oncology drug development for pharma/biotech using modeling and simulation.

PYC | IL

Overview

Corporate Details

ISIN(s):
GB00BDR6W943
LEI:
213800A71DSZ6ABMTQ91
Country:
United Kingdom
Address:
BEE HOUSE, OX14 4SB ABINGDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Physiomics PLC is a data-driven consultancy that accelerates and de-risks drug development for pharmaceutical and biotech companies. The company provides Model-Informed Drug Development (MIDD) services by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. Specializing in quantitative pharmacology (PK/PD, QSP) and computational biology, Physiomics enables clients to make smarter decisions from pre-clinical discovery through to clinical trials. With a strong focus on oncology, the company utilizes mathematical models and its Virtual Tumour™ technology to predict the effects of novel treatments, providing a more quantitative and translational understanding of new molecules.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 08:00
Annual Report
Annual Financial Report
English 604.1 KB
2025-09-22 08:00
Report Publication Announcement
Notice of Results and Investor Presentation
English 11.4 KB
2025-08-06 08:00
Regulatory News Service
Follow-on Contract with UK Biotech Client
English 9.5 KB
2025-07-16 08:00
Regulatory News Service
Contract Award
English 9.5 KB
2025-07-14 08:00
Earnings Release
Trading Update
English 12.0 KB
2025-07-10 08:00
Regulatory News Service
Platform Implementation and Partnership Expansion
English 17.6 KB
2025-05-29 08:00
Regulatory News Service
Physiomics Awarded Contract Extension
English 9.6 KB
2025-03-17 08:00
Regulatory News Service
Contract Award with new client
English 8.8 KB
2025-03-13 08:00
Report Publication Announcement
IMC Presentation on Company Website
English 8.3 KB
2025-03-06 08:00
Earnings Release
Interim Results
English 165.4 KB
2025-02-28 08:00
Report Publication Announcement
Notice of Results and Investor Presentation
English 10.0 KB
2025-02-20 13:00
Major Shareholding Notification
Holding(s) in Company
English 52.0 KB
2025-02-17 14:00
Share Issue/Capital Change
Result of WRAP Retail Offer
English 14.5 KB
2025-02-13 08:01
Share Issue/Capital Change
WRAP Retail Offer for up to £70,000
English 28.6 KB
2025-02-13 08:00
Share Issue/Capital Change
Completion of Placing & WRAP Retail Offer Launch
English 18.5 KB

Automate Your Workflow. Get a real-time feed of all PHYSIOMICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PHYSIOMICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany MOR
Mycodern Spolka Akcyjna Logo Poland MCD
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC

Talk to a Data Expert

Have a question? We'll get back to you promptly.